1,018 filings
Page 5 of 51
144
FGEN
FibroGen Inc
8 Jun 23
Notice of proposed sale of securities
5:51pm
144
Juan Graham
7 Jun 23
Notice of proposed sale of securities
9:51pm
144
FGEN
FibroGen Inc
7 Jun 23
Notice of proposed sale of securities
9:41pm
144
FGEN
FibroGen Inc
7 Jun 23
Notice of proposed sale of securities
9:36pm
144
FGEN
FibroGen Inc
7 Jun 23
Notice of proposed sale of securities
9:31pm
144
Schoeneck James A
7 Jun 23
Notice of proposed sale of securities
10:34am
8-K
FGEN
FibroGen Inc
7 Jun 23
FibroGen Announces Topline Results from LELANTOS-1 Phase 3 Clinical Study of Pamrevlumab in Non-Ambulatory Patients with Duchenne Muscular Dystrophy
9:00am
4
Mark Eisner
5 Jun 23
FIBROGEN / Mark Eisner ownership change
4:22pm
144
Mark Eisner
2 Jun 23
Notice of proposed sale of securities
8:53pm
DEFA14A
FGEN
FibroGen Inc
31 May 23
Additional proxy soliciting materials
9:00am
8-K
FGEN
FibroGen Inc
18 May 23
FibroGen Announces Positive Topline Results from China Pivotal Phase 3 Clinical Trial of Roxadustat for the Treatment of Chemotherapy Induced Anemia
7:35am
10-Q
2023 Q1
FGEN
FibroGen Inc
Quarterly report
8 May 23
4:12pm
8-K
FGEN
FibroGen Inc
8 May 23
FibroGen Reports First Quarter 2023 Financial Results
4:06pm
8-K
FGEN
FibroGen Inc
1 May 23
Entry into a Material Definitive Agreement
4:48pm
ARS
2022 FY
FGEN
FibroGen Inc
27 Apr 23
Annual report to shareholders
4:17pm
DEFA14A
FGEN
FibroGen Inc
27 Apr 23
Additional proxy soliciting materials
4:10pm
DEF 14A
FGEN
FibroGen Inc
Definitive proxy
27 Apr 23
4:06pm
4
Conterno Enrique A
11 Apr 23
FIBROGEN / Enrique A Conterno ownership change
4:59pm
4
Mark Eisner
6 Apr 23
FIBROGEN / Mark Eisner ownership change
4:32pm
4
Chung Christine
6 Apr 23
FIBROGEN / Christine Chung ownership change
4:28pm